...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    cprx-img

    Catalyst Pharmaceuticals Inc, Common Stock

    CPRX

    NAQ

    $22.05

    +$0.6

    (2.8%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $2.61B
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     16.374
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     1.11M
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0.79
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $14.47 L
    $26.16 H
    $22.05

    About Catalyst Pharmaceuticals Inc, Common Stock

    Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameCPRXSectorS&P500
    1-Week Return-4.42%-0.29%3.55%
    1-Month Return5.2%-7.65%-5.72%
    3-Month Return-0.72%-4.64%-9.82%
    6-Month Return9.16%-12.35%-9.51%
    1-Year Return39.47%-4.34%1.26%
    3-Year Return174.94%-3.64%19.2%
    5-Year Return405.73%43.5%90.39%
    10-Year Return370.15%83.13%151.51%

    Financials

    Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
    Total Revenue119.07M140.83M214.20M398.20M491.73M[{"date":"2020-12-31","value":24.21,"profit":true},{"date":"2021-12-31","value":28.64,"profit":true},{"date":"2022-12-31","value":43.56,"profit":true},{"date":"2023-12-31","value":80.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Cost of Revenue17.04M21.88M34.39M84.53M68.84M[{"date":"2020-12-31","value":20.16,"profit":true},{"date":"2021-12-31","value":25.89,"profit":true},{"date":"2022-12-31","value":40.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":81.44,"profit":true}]
    Gross Profit102.03M118.95M179.81M313.67M422.89M[{"date":"2020-12-31","value":24.13,"profit":true},{"date":"2021-12-31","value":28.13,"profit":true},{"date":"2022-12-31","value":42.52,"profit":true},{"date":"2023-12-31","value":74.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Gross Margin85.69%84.46%83.94%78.77%86.00%[{"date":"2020-12-31","value":99.64,"profit":true},{"date":"2021-12-31","value":98.21,"profit":true},{"date":"2022-12-31","value":97.61,"profit":true},{"date":"2023-12-31","value":91.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Operating Expenses60.73M66.56M77.97M259.43M227.76M[{"date":"2020-12-31","value":23.41,"profit":true},{"date":"2021-12-31","value":25.66,"profit":true},{"date":"2022-12-31","value":30.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.8,"profit":true}]
    Operating Income41.30M52.38M101.84M86.81M195.12M[{"date":"2020-12-31","value":21.17,"profit":true},{"date":"2021-12-31","value":26.85,"profit":true},{"date":"2022-12-31","value":52.19,"profit":true},{"date":"2023-12-31","value":44.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Total Non-Operating Income/Expense---12.37M37.20M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":33.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Pre-Tax Income41.89M52.67M104.72M94.51M216.26M[{"date":"2020-12-31","value":19.37,"profit":true},{"date":"2021-12-31","value":24.35,"profit":true},{"date":"2022-12-31","value":48.42,"profit":true},{"date":"2023-12-31","value":43.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Income Taxes(33.09M)13.19M21.64M23.10M52.37M[{"date":"2020-12-31","value":-63.19,"profit":false},{"date":"2021-12-31","value":25.17,"profit":true},{"date":"2022-12-31","value":41.32,"profit":true},{"date":"2023-12-31","value":44.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Income After Taxes---71.41M163.89M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":43.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Income From Continuous Operations74.98M39.48M83.08M62.04M163.89M[{"date":"2020-12-31","value":45.75,"profit":true},{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":50.69,"profit":true},{"date":"2023-12-31","value":37.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income74.98M39.48M83.08M71.41M163.89M[{"date":"2020-12-31","value":45.75,"profit":true},{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":50.69,"profit":true},{"date":"2023-12-31","value":43.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    EPS (Diluted)0.410.370.740.811.57[{"date":"2020-12-31","value":26.11,"profit":true},{"date":"2021-12-31","value":23.57,"profit":true},{"date":"2022-12-31","value":47.13,"profit":true},{"date":"2023-12-31","value":51.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    CPRX
    Cash Ratio 4.29
    Current Ratio 5.17
    Quick Ratio 5.01

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    CPRX
    ROA (LTM) 18.46%
    ROE (LTM) 29.38%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    CPRX
    Debt Ratio Lower is generally better. Negative is bad. 0.15
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.85

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    CPRX
    Trailing PE 16.83
    Forward PE 12.27
    P/S (TTM) 5.45
    P/B 3.58
    Price/FCF 38
    EV/R 4.26
    EV/Ebitda 8.98
    PEG NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Catalyst Pharmaceuticals Inc share price today?

    Catalyst Pharmaceuticals Inc (CPRX) share price today is $22.05

    Can Indians buy Catalyst Pharmaceuticals Inc shares?

    Yes, Indians can buy shares of Catalyst Pharmaceuticals Inc (CPRX) on Vested. To buy Catalyst Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CPRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Catalyst Pharmaceuticals Inc be purchased?

    Yes, you can purchase fractional shares of Catalyst Pharmaceuticals Inc (CPRX) via the Vested app. You can start investing in Catalyst Pharmaceuticals Inc (CPRX) with a minimum investment of $1.

    How to invest in Catalyst Pharmaceuticals Inc shares from India?

    You can invest in shares of Catalyst Pharmaceuticals Inc (CPRX) via Vested in three simple steps:

    • Click on Sign Up or Invest in CPRX stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Catalyst Pharmaceuticals Inc shares
    What is Catalyst Pharmaceuticals Inc 52-week high and low stock price?

    The 52-week high price of Catalyst Pharmaceuticals Inc (CPRX) is $26.16. The 52-week low price of Catalyst Pharmaceuticals Inc (CPRX) is $14.47.

    What is Catalyst Pharmaceuticals Inc price-to-earnings (P/E) ratio?

    The price-to-earnings (P/E) ratio of Catalyst Pharmaceuticals Inc (CPRX) is 16.374

    What is Catalyst Pharmaceuticals Inc price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Catalyst Pharmaceuticals Inc (CPRX) is 3.58

    What is the Market Cap of Catalyst Pharmaceuticals Inc?

    The market capitalization of Catalyst Pharmaceuticals Inc (CPRX) is $2.61B

    What is Catalyst Pharmaceuticals Inc’s stock symbol?

    The stock symbol (or ticker) of Catalyst Pharmaceuticals Inc is CPRX

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top